Related Experiment Video
Updated: Sep 20, 2026

Simulation of a Scaled Assembly Process with Collaboration of a Robotic Arm and Monitoring through a Vision System for Quality Control
Published on: August 29, 2025
A quantitative assessment of factors influencing the probability of postmarketing out-of-specification observations
1Flower Valley Consulting, Inc., Rockville, Maryland 20853, USA. fairweather@flowervalleyconsulting.com
Abstract:
When marketed lots of pharmaceutical products produce a number of out-of-specification (OOS) samples, it can be very disruptive. In some cases such lots must be recalled, at substantial expense. We present a model of the probability of OOS samples and show quantitatively how this probability depends on the underlying variation and on the original stability study. We describe the limited situations in which sponsors can reduce the probability of OOS samples.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Detection of Gross Error: The Q Test
Statistical Analysis: Overview
One of the most commonly used statistical quantifiers is the mean, which is the ratio between the sum of the numerical values of all results and the...
Quantifying and Rejecting Outliers: The Grubbs Test
Clinically Relevant Drug Product Specifications: Methods of Establishment
Difference from Background: Limit of Detection
The LOD indicates the presence or absence...
